S. Dhumal

发表

Distress Management in Patients With Head and Neck Cancer Before Start of Palliative Chemotherapy: A Practical Approach

J. Deodhar, K. Prabhash, S. Chakraborty, 2018, Journal of global oncology.

Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients

A. Bhattacharjee, K. Prabhash, V. Noronha, 2018, South Asian journal of cancer.

A tertiary care experience with paclitaxel and cetuximab as palliative chemotherapy in platinum sensitive and nonsensitive in head and neck cancers

S. Arya, A. Bhattacharjee, K. Prabhash, 2017, South Asian Journal of Cancer.

Technically unresectable recurrent oral cancers: Is NACT the answer?

A. Mahajan, S. Arya, P. Pai, 2016, Oral oncology.

A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck.

S. Arya, A. Bhattacharjee, K. Prabhash, 2015, Oral oncology.

Metronomic chemotherapy in platinum-insensitive failures and/or early failures postmultimodality management in oral cancers

A. Bhattacharjee, K. Prabhash, R. Pinninti, 2015, Indian Journal of Medical and Paediatric Oncology.

Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid

K. Prabhash, V. Noronha, V. Rangarajan, 2019, South Asian Journal of Cancer.

Compliance With Neoadjuvant Chemotherapy in T4 Oral Cancers: Place, Person, Socioeconomic Status, or Assistance

A. Bhattacharjee, K. Prabhash, V. Noronha, 2015, Journal of global oncology.

Effect of Early Palliative Care on Quality of Life of Advanced Head and Neck Cancer Patients: A Phase III Trial.

N. Salins, M. Muckaden, J. Deodhar, 2021, Journal of the National Cancer Institute.

N Gene Target Failure (NGTF) for detection of Omicron: a way out for the "stealth" too?

S. Nair, Sudeep Gupta, V. Murthy, 2022, medRxiv.

Expectations and preferences for palliative chemotherapy in head and neck cancers patients.

J. Deodhar, A. Bhattacharjee, K. Prabhash, 2016, Oral oncology.

Metronomic palliative chemotherapy in maxillary sinus tumor

K. Prabhash, V. Patil, A. Joshi, 2016, South Asian Journal of Cancer.

Long term toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin-ineligible head and neck cancer patients.

K. Prabhash, V. Noronha, V. Patil, 2022, Oral oncology.

Neoadjuvant chemotherapy in geriatric head and neck cancers

A. Mahajan, S. Arya, A. Bhattacharjee, 2017, Head & neck.

Neoadjuvant chemotherapy and surgical margin in technically unresectable buccal mucosa cancers.

K. Prabhash, A. D'cruz, V. Noronha, 2015, Oral oncology.

Neoadjuvant Chemotherapy in Locally Advanced and Borderline Resectable Nonsquamous Sinonasal Tumors (Esthesioneuroblastoma and Sinonasal Tumor with Neuroendocrine Differentiation)

P. Pai, A. Bhattacharjee, K. Prabhash, 2016, International journal of surgical oncology.

Weekly chemotherapy as Induction chemotherapy in locally advanced head and neck cancer for patients ineligible for 3 weekly maximum tolerable dose chemotherapy.

S. Arya, P. Pai, A. D'cruz, 2014, Indian journal of cancer.

Diclofenac versus tramadol for mucositis related pain in head and neck cancer patients undergoing concurrent chemoradiation—a phase 3 study

A. Bhattacharjee, P. Jain, K. Prabhash, 2021, Ecancermedicalscience.

Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai

R. Dikshit, P. Chaturvedi, S. Nair, 2022, International journal of clinical practice.

Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study

A. Mahajan, A. Bhattacharjee, K. Prabhash, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.

A. Mahajan, A. Bhattacharjee, K. Prabhash, 2020, The Lancet. Global health.

Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer.

A. Mahajan, M. Mahimkar, A. Bhattacharjee, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

P. Chaturvedi, S. Kannan, A. Mahajan, 2019, Cancer.

Audit of screen failure in 15 randomised studies from a low and middle-income country

K. Prabhash, V. Noronha, V. Patil, 2022, Ecancermedicalscience.

Long-term survival outcomes of technically unresectable carcinoma maxilla postinduction chemotherapy

P. Pai, K. Prabhash, V. Noronha, 2018, South Asian Journal of Cancer.

Induction Chemotherapy in Technically Unresectable Locally Advanced Carcinoma of Maxillary Sinus

P. Pai, K. Prabhash, J. Agarwal, 2014, Chemotherapy research and practice.

Referral pattern for neoadjuvant chemotherapy in the head and neck cancers in a tertiary care center.

K. Prabhash, V. Noronha, D. Chaukar, 2014, Indian journal of cancer.

Beyond conventional chemotherapy, targeted therapy and immunotherapy in squamous cell cancer of the oral cavity.

K. Prabhash, V. Noronha, V. Patil, 2020, Oral oncology.

Outcomes of operable oral cavity cancer in rural India: A retrospective study

S. Arya, K. Prabhash, A. D'cruz, 2022 .

Neoadjuvant chemotherapy in technically unresectable carcinoma of external auditory canal

S. Arya, K. Prabhash, J. Agarwal, 2015, Indian Journal of Medical and Paediatric Oncology.

Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers.

S. Arya, P. Pai, K. Prabhash, 2014, Oral oncology.

NACT in locally advanced oral cancers : Does HPV make a difference?

S. Arya, A. Bhattacharjee, K. Prabhash, 2015 .

Neoadjuvant chemotherapy in advanced sinonasal teratocarcinosarcoma with intracranial extension: Report of two cases with literature review.

P. Pai, K. Prabhash, V. Noronha, 2015, Journal of cancer research and therapeutics.

865MO RMAC study: A randomized study evaluating the efficacy of metronomic adjuvant chemotherapy in patients with recurrent head and neck cancers post salvage surgery, not eligible for re-irradiation

A. Bhattacharjee, K. Prabhash, V. Noronha, 2021, Annals of Oncology.

Efficacy of second-line erlotinib in patients postprogression of first-line chemotherapy in head and neck cancers.

A. Bhattacharjee, K. Prabhash, V. Noronha, 2015, Indian journal of cancer.

SARS-CoV-2 reinfection after previous infection and vaccine breakthrough infection through the second wave of pandemic in India: An observational study

S. Gupta, S. Kannan, A. Bhattacharjee, 2022, International Journal of Infectious Diseases.

Palliative chemotherapy in carcinoma nasopharynx

K. Prabhash, V. Noronha, V. Patil, 2019, South Asian Journal of Cancer.

Neoadjuvant Chemotherapy in Technically Unresectable Oral Cancers: Does Human Papillomavirus Make a Difference?

S. Arya, A. Bhattacharjee, K. Prabhash, 2015, Clinics in oncology.

Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer.

A. Mahajan, S. Arya, A. Bhattacharjee, 2017, Oral oncology.

Cisplatin based adjuvant chemoradiation following neoadjuvant chemotherapy and surgery in advanced oral cavity cancers: A deliverable regimen?

K. Prabhash, J. Agarwal, V. Noronha, 2016, Indian Journal of Cancer.

Predictivity of human papillomavirus positivity in advanced oral cancer.

A. Bhattacharjee, K. Prabhash, A. D'cruz, 2015, Indian journal of cancer.

Long term outcomes of a randomized controlled clinical trial comparing the efficacy of Cabazitaxel versus docetaxel as second-line or above therapy in recurrent head and neck cancer.

A. Bhattacharjee, K. Prabhash, V. Noronha, 2022, Oral oncology.

Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer.

K. Prabhash, V. Noronha, S. Laskar, 2024, European journal of cancer.

Quality of life without toxicity or symptoms analysis of a randomized controlled clinical trial comparing efficacy of cabazitaxel versus docetaxel in recurrent head and neck cancer

A. Mahajan, A. Bhattacharjee, K. Prabhash, 2018, Cancer Research, Statistics, and Treatment.

Nivolumab in platinum-refractory head-and-neck cancers: A retrospective observational audit from a tertiary cancer center

V. Noronha, V. Patil, S. Dhumal, 2022, Cancer Research, Statistics, and Treatment.

The pattern of care in head-and-neck cancer: Comparison between before and during the COVID-19 pandemic

K. Prabhash, V. Noronha, V. Patil, 2020 .

Selected current data on metronomic therapy (and its promise) from India

K. Prabhash, V. Noronha, P. Parikh, 2016, South Asian Journal of Cancer.

The Pattern of Care of Use of Nivolumab in Head and Neck Cancers - Audit From a Tertiary Cancer Centre.

K. Prabhash, V. Noronha, V. Patil, 2021, Clinical oncology (Royal College of Radiologists (Great Britain)).